We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.51B
AUM Growth
+$99.7M
Cap. Flow
-$170M
Cap. Flow %
-3.09%
Top 10 Hldgs %
18.48%
Holding
1,445
New
336
Increased
635
Reduced
341
Closed
112

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$53.9M
2
PDD icon
Pinduoduo
PDD
+$47.7M
3
LOGC
ContextLogic
LOGC
+$25.5M
4
TDUP icon
ThredUp
TDUP
+$25.1M
5
UPWK icon
Upwork
UPWK
+$24.9M

Top Sells

Rank Stock Value
1
RVLV icon
Revolve Group
RVLV
+$66M
2
NTES icon
NetEase
NTES
+$50.7M
3
TRIP icon
TripAdvisor
TRIP
+$46.2M
4
GRPN icon
Groupon
GRPN
+$44.5M
5
QVCGA
QVC Group Inc Series A
QVCGA
+$43.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30%
2 Technology 24.74%
3 Communication Services 13.13%
4 Financials 5.61%
5 Industrials 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HARP
1276
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$10K ﹤0.01%
74
+1
+1% +$191
CTMX icon
1277
CytomX Therapeutics
CTMX
$754M
$9K ﹤0.01%
1,480
+5
+0.3% +$39
INZY
1278
DELISTED
Inozyme Pharma
INZY
$9K ﹤0.01%
535
+5
+0.9% +$87
SPRO icon
1279
Spero Therapeutics
SPRO
$73M
$9K ﹤0.01%
675
+55
+9% +$769
QTTB icon
1280
Q32 Bio
QTTB
$464M
$9K ﹤0.01%
72
+15
+26% +$1.87K
ATNX
1281
DELISTED
Athenex, Inc. Common Stock
ATNX
$9K ﹤0.01%
107
+1
+0.9% +$91
AKUS
1282
DELISTED
Akouos Inc
AKUS
$9K ﹤0.01%
785
+10
+1% +$136
FLXN
1283
DELISTED
Flexion Therapeutics, Inc.
FLXN
$9K ﹤0.01%
1,135
+20
+2% +$170
ALT icon
1284
Altimmune
ALT
$599M
$8K ﹤0.01%
875
+30
+4% +$410
AUTL
1285
Autolus Therapeutics
AUTL
$562M
$8K ﹤0.01%
1,230
+460
+60% +$2.85K
AVDL
1286
DELISTED
Avadel Pharmaceuticals
AVDL
$8K ﹤0.01%
1,330
+5
+0.4% +$40
NGNE icon
1287
Neurogene
NGNE
$712M
$8K ﹤0.01%
48
– –
PBYI icon
1288
Puma Biotechnology
PBYI
$454M
$8K ﹤0.01%
920
+15
+2% +$152
TECX
1289
Tectonic Therapeutic
TECX
$606M
$8K ﹤0.01%
79
+1
+1% +$119
GMDA
1290
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$8K ﹤0.01%
1,350
– –
BDSI
1291
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8K ﹤0.01%
2,245
-65
-3% -$229
ACET icon
1292
Adicet Bio
ACET
$74.7M
$7K ﹤0.01%
45
+2
+5% +$407
ADVM
1293
DELISTED
Adverum Biotechnologies
ADVM
$7K ﹤0.01%
223
+2
+0.9% +$108
FULC icon
1294
Fulcrum Therapeutics
FULC
$297M
$7K ﹤0.01%
745
+20
+3% +$202
KALA icon
1295
KALA BIO
KALA
$14.5M
$7K ﹤0.01%
1
– –
KRRO icon
1296
Korro Bio
KRRO
$195M
$7K ﹤0.01%
16
+1
+7% +$488
RDHL
1297
Redhill Biopharma
RDHL
$3.68M
$7K ﹤0.01%
1
– –
SYRE icon
1298
Spyre Therapeutics
SYRE
$9.25B
$7K ﹤0.01%
45
+1
+2% +$182
URGN icon
1299
UroGen Pharma
URGN
$2.29B
$7K ﹤0.01%
510
+15
+3% +$271
WVE icon
1300
Wave Life Sciences
WVE
$1.2B
$7K ﹤0.01%
1,135
+25
+2% +$163
50 51
52
53 54

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Penserra Capital Management held 1,445 positions worth $5.51B, up 1.8% from $5.41B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management withdrew a net $170M in Q2 2021, closing 112 positions and reducing 341 holdings. Its most notable exit was Just Eat Takeaway.com N.V. American Depositary Shares, an estimated $23.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Penserra Capital Management opened a new position in ContextLogic worth $28.5M.

  • Penserra Capital Management's largest Q2 2021 buy was ContextLogic: 72,047 shares worth $28.5M.
  • Penserra Capital Management added most to Advanced Micro Devices in Q2 2021, an estimated $53.9M increase.
  • Penserra Capital Management's biggest Q2 2021 reduction was Revolve Group, cutting an estimated $66M.
  • Penserra Capital Management fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, selling an estimated $23.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $5.51B portfolio in Q2 2021.
  • Penserra Capital Management opened 336 new positions and closed 112 in Q2 2021.
  • Penserra Capital Management's portfolio value rose 1.8% quarter-over-quarter to $5.51B.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.